Gland Pharma Ltd. Company Cash Flow Statement & Analysis

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Profit Before Tax	1,748.31	1,465.59	1,405.50	1,048.40	1,619.04
Net CashFlow-Operating Activity	1,135.23	1,073.67	1,135.97	367.89	791.29
Net Cash Used In Investing Activity	-95.56	1,578.20	-2,923.92	1,208.22	-1,010.23
NetCash Used in Fin. Activity	-316.18	-339.54	-7.40	14.92	34.90
Net Inc/Dec In Cash And Equivlnt	745.02	2,316.42	-1,789.01	1,594.04	-180.73
Cash And Equivalnt Begin of Year	2,432.62	116.20	1,905.22	311.18	491.92
Cash And Equivalnt End Of Year	3,177.64	2,432.62	116.20	1,905.22	311.18

കൂടുതൽ »

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article